about
HE4 expression is associated with hormonal elements and mediated by importin-dependent nuclear translocationRevisiting the role of antiandrogen strategies in ovarian cancer.Endometrioid ovarian carcinoma benefits from aromatase inhibitors: case report and literature reviewTreatment of platinum-resistant ovarian cancer.A mathematical model of bimodal epigenetic control of miR-193a in ovarian cancer stem cellsNew insights on the role of hormonal therapy in ovarian cancerProliferation of the superficial epithelium of ovaries in senile female rats following oral administration of conjugated equine estrogens.High expression of orphan nuclear receptor NR4A1 in a subset of ovarian tumors with worse outcome.Optimal treatment for relapsing ovarian cancer.Expression of estrogen and progesterone receptors across human malignancies: new therapeutic opportunities.Role of GPER on proliferation, migration and invasion in ligand-independent manner in human ovarian cancer cell line SKOV3.Estrogen induction and overexpression of fibulin-1C mRNA in ovarian cancer cells.Estrogen receptor gene amplification occurs rarely in ovarian cancer.Activation of estrogen receptor α by estradiol and cisplatin induces platinum-resistance in ovarian cancer cells.StAR and progesterone producing enzymes (3beta-hydroxysteroid dehydrogenase and cholesterol side-chain cleavage cytochromes P450) in human epithelial ovarian carcinoma: immunohistochemical and real-time PCR studies.Complete response to orally administered melphalan in malignant pleural effusion from an occult female genital organ primary neoplasm with BRCA1/2 mutations: a case report.
P2860
Q33820206-45B9A33E-E821-4606-B554-915298D348FCQ34219464-389A76AB-CF67-4406-BF38-788164848101Q34359434-7FFDF125-7738-40A1-8A89-FB88D9E2CCA1Q34390236-D26482E9-266E-4D73-B0BE-DF51EC2732D3Q34784456-A0ECD482-EA54-4B8A-808E-8B04DEC5F84FQ36001247-72D51ECE-6515-4F01-AF8A-5E8DA4AAD387Q37147427-73CBFEB2-4139-4510-83A4-959D54E27EDEQ37500390-989C0044-C707-45F0-80A4-A7A24A976B57Q37799929-08527F81-2ADF-46EE-AEE7-8EBCF231579AQ38301592-BB04D743-D03C-4FD2-9FD4-063862110B63Q38822791-3152B4B3-BACF-473A-9307-D25402869411Q40750156-1F8F7D9A-D571-4B01-92CF-3F501FB9C74AQ44039602-7A6083FC-6F32-4DC8-BE2A-30CDA2576959Q46425884-74267F0D-BD8A-4598-8B16-BFF44F49796EQ46429042-FC8108E0-63BE-43DF-98FD-480E36A1DBE2Q55316688-FDD7886E-6A27-4D43-B3F7-E18093842D1C
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Hormone therapy in epithelial ovarian cancer.
@ast
Hormone therapy in epithelial ovarian cancer.
@en
type
label
Hormone therapy in epithelial ovarian cancer.
@ast
Hormone therapy in epithelial ovarian cancer.
@en
prefLabel
Hormone therapy in epithelial ovarian cancer.
@ast
Hormone therapy in epithelial ovarian cancer.
@en
P356
P1476
Hormone therapy in epithelial ovarian cancer.
@en
P2093
P356
10.1677/ERC.0.0070085
P577
2000-06-01T00:00:00Z